Clinical Stratification and Demographic Profiling of Patients with Insulin Resistance and Type 2 Diabetes Mellitus: A Cross-Sectional Study
DOI:
https://doi.org/10.36320/ajb/v17.i2.19549Keywords:
: Insulin resistance, Type 2 diabetes mellitus, Clinical stratification, Hypertension, Autoimmune diseases.Abstract
The increasing global health concern of insulin resistance (IR) and type 2 diabetes mellitus (T2DM) highlights the need for improved patient categorization to better understand the various forms of these conditions and inform individualized treatment plans. This research sought to systematically group 100 participants based on the presence or absence of IR and T2DM, subsequently examining demographic and clinical characteristics such as age, gender, the occurrence of autoimmune diseases, and hypertension rates within these defined groups. The study's findings revealed significant differences in the distribution of these factors across the cohorts. Specifically, older age and co-existing hypertension were more common in individuals with both T2DM and IR, while autoimmune diseases were more frequently seen in those with T2DM, irrespective of whether they also had IR. In conclusion, classifying patients using clinical and demographic features offers important understanding into the diverse nature of metabolic disorders, a stratification that is crucial for refining diagnostic and treatment approaches tailored to specific patient subgroups.
Downloads
References
1. Pappachan, J.M., C.J. Fernandez, and A.P. Ashraf, Rising tide: the global surge of type 2 diabetes in children and adolescents demands action now. World Journal of Diabetes, 2024. 15(5): p. 797.
2. Accili, D., Z. Deng, and Q. Liu, Insulin resistance in type 2 diabetes mellitus. Nature Reviews Endocrinology, 2025: p. 1-14.
3. Zhao, Y. and R. Yue, Aging adipose tissue, insulin resistance, and type 2 diabetes. Biogerontology, 2024. 25(1): p. 53-69.
4. Nadhiya, J., M. Vijayalakshmi, and S. Showbharnikhaa, A Brief Review on Diabetes Mellitus. Journal of Pharma Insights and Research, 2024. 2(1): p. 117-121.
5. Dama, A., et al., Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation. Nutrients, 2024. 16(4): p. 507.
6. Dakal, T.C., et al., Lipids dysregulation in diseases: core concepts, targets and treatment strategies. Lipids in Health and Disease, 2025. 24(1): p. 61.
7. Zuboon, H. and M.I. Mohsin, Evaluate Interleukin-15 in SLE patients and its association with hemolytic anemia. Magazine of Al-Kufa University for Biology, 2024. 16(2).
8. Hasan, H., J. Jouda, and Y. Saihood, The Effect of Body Weight Gain with or Without Diabetes Type 2 on the Levels of Noradrenalin and Some Neurotrophins. Magazine of Al-Kufa University for Biology, 2023. 15(2).
9. Jaafar, M.R., et al., Evaluation of (HbA1c, Creatinine, Dopamine receptor2, Insulin, Glutathione, Lipidperoxidase) in type 2 diabetes mellitus patients. Magazine of Al-Kufa University for Biology, 2025. 17(1).
10. Jassim, W.E. and A.A. Hussein, " Insulin Resistance, Lipid Profile, C-Peptide, and Their Interplay in Type 2 Diabetes: A Basrah Population Study". Magazine of Al-Kufa University for Biology, 2024. 16(3).
11. Franks, P.W. and J.L. Sargent, Diabetes and obesity: leveraging heterogeneity for precision medicine. European Heart Journal, 2024. 45(48): p. 5146-5155.
12. Taylor, R., Understanding the cause of type 2 diabetes. The Lancet Diabetes & Endocrinology, 2024.
13. Yasmeen, F., et al., Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies. International Journal of Molecular Sciences, 2024. 25(14): p. 7666.
14. Nautiyal, G., et al., Autoimmune Diseases: Recent Insights on Epidemiology, Pathogenesis, and Prevalence Rate. Artificial Intelligence and Autoimmune Diseases: Applications in the Diagnosis, Prognosis, and Therapeutics, 2024: p. 33-58.
15. Bergmann, F., et al., Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta‐analysis. Journal of Internal Medicine, 2025.
16. Novoselova, E.G., et al., Pancreas Β-Cells in Type 1 and Type 2 Diabetes: Cell Death, Oxidative Stress and Immune Regulation. Recently Appearing Changes in Diabetes Consequences. Cell Physiol Biochem, 2024. 58(2): p. 144-155.
17. Chauhan, A., S. Dubey, and S. Jain, Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets. Cell Biochemistry and Function, 2024. 42(7): p. e4111.
18. Alexander, M., et al., Pathology of Diabetes-Induced Immune Dysfunction. International Journal of Molecular Sciences, 2024. 25(13): p. 7105.
19. Rangareddy, H., et al., Inflammaging and microbiota: the intersection of aging, inflammation, and gut health. Aging Pathobiology and Therapeutics, 2025. 7(2).
20. Shi, Y., et al., Sex difference in human diseases: mechanistic insights and clinical implications. Signal transduction and targeted therapy, 2024. 9(1): p. 238.
21. Sánchez-García, M., et al., Metabolic Changes in Patients with Premature Ovarian Insufficiency: Adipose Tissue Focus—A Narrative Review. Metabolites, 2025. 15(4): p. 242.
22. Santoso, C., et al., Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults. Diabetologia, 2025. 68(2): p. 331-341.
23. Zhou, Z., et al., Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM? Diabetology & Metabolic Syndrome, 2024. 16(1): p. 242.
24. Savvopoulos, S., H. Hatzikirou, and H.F. Jelinek, Comparative analysis of biomarkers in type 2 diabetes patients with and without comorbidities: insights into the role of hypertension and cardiovascular disease. Biomarker insights, 2024. 19: p. 11772719231222111.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muslim Idan Mohsin
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
